Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Learn about the signs and symptoms of rhabdomyosarcoma, the tests that may be done for it, and the outlook for those with a diagnosis.
Rhabdomyosarcoma (RMS) is not common, and at this time there are no recommended screening tests for these cancers. Screening is testing for a disease such as cancer in people who do not have any symptoms.
Families known to carry inherited conditions that raise the risk of RMS (listed in Rhabdomyosarcoma Causes, Risk Factors, and Prevention) or that have several family members with cancer (particularly childhood cancers) should talk with their doctors about the possible need for more frequent checkups. It is not common for RMS to run in families, but close attention to possible early signs of cancer might help find it early.
RMS can lead to symptoms that cause a child to go to the doctor. Symptoms from RMS depend on the location of the tumor. Symptoms can include:
Most symptoms that might point to RMS, such as pain, swelling and lumps, can also have other causes. Most of these symptoms are not from cancer. But if they persist or do not go away after a week or so, it is important to have them checked by a doctor.
Diagnosing RMS often involves imaging tests, blood work and a biopsy of the tumor. If RMS is found, more detailed tests will be done on the tumor sample, and a bone marrow biopsy will be done to learn more about the RMS and if it has spread to decide how best to treat it.
Some of these tests are also used to track how well treatment is working.
After a rhabdomyosarcoma diagnosis, many people want to understand what to expect. Doctors use information about a tumor’s location, stage (extent), whether or not it can be removed with surgery and gene changes to assign a risk group. Risk groups refer to how likely it is that the cancer might recur or come back after treatment. They are used to decide what treatment is best for each specific case.
Risk groups are important in estimating a child’s outlook (prognosis) for survival.
Survival rates are a way to measure how many people survive a certain type of cancer over time. Survival rates are often reported as 5-year survival rates, which refer to the percentage of children who live at least 5 years after their cancer diagnosis. Of course, many children live much longer than 5 years (and many are cured). Some people find this information helpful, while others prefer to focus more on treatment plans and next steps.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Linardic CM, Wexler, LH. Chapter 25: Rhabdomyosarcoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2021.
Okcu MF, Hicks J. Rhabdomyosarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging. UpToDate. 2025. Accessed at www.uptodate.com/contents/rhabdomyosarcoma-in-childhood-and-adolescence-clinical-presentation-diagnostic-evaluation-and-staging on April 3, 2025.
Last Revised: June 2, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.